2020 – iCo Therapeutics

Bertilimumab/iCo-008 Project

ico_admin2021-02-21T21:40:49+00:00January 1st, 2021|2020, Presentations|

Vancouver, British Columbia--(Newsfile Corp. - December 31, 2020) - iCo Therapeutics (TSXV: ICO) (OTCQB: ICOTF)

ico_admin2021-02-18T21:54:27+00:00December 31st, 2020|2020, Press Releases|

ico_admin2021-02-21T21:41:08+00:00December 1st, 2020|2020, Presentations|

Vancouver, British Columbia--(Newsfile Corp. - November 24, 2020) - iCo Therapeutics (TSXV: ICO) (OTCQB: ICOTF)

ico_admin2021-02-18T21:54:33+00:00November 24th, 2020|2020, Press Releases|

ico_admin2021-02-21T21:45:08+00:00November 1st, 2020|2020, Articles|

Vancouver, British Columbia--(Newsfile Corp. - October 26, 2020) - iCo Therapeutics (TSXV: ICO) (OTCQB: ICOTF)

ico_admin2021-02-18T21:54:39+00:00October 26th, 2020|2020, Press Releases|

Vancouver, British Columbia--(Newsfile Corp. - October 21, 2020) - iCo Therapeutics Inc. (TSXV: ICO) (OTCQB:

ico_admin2021-02-20T03:20:45+00:00October 21st, 2020|2020, Press Releases|

ico_admin2021-02-21T21:39:10+00:00October 1st, 2020|2020, Presentations|

ico_admin2021-02-21T21:39:37+00:00October 1st, 2020|2020, Presentations|

Vancouver, British Columbia--(Newsfile Corp. - August 31, 2020) - iCo Therapeutics (TSXV: ICO) (OTCQB: ICOTF)

ico_admin2021-02-20T03:20:09+00:00August 31st, 2020|2020, Press Releases|